NaughtonCA. Drug-induced nephrotoxicity. Am Fam Physician. 2008;78(6):743–750.
3.
NashKHafeezAHouS. Hospital-acquired renal insufficiency. Am J Kidney Dis. 2002;39(5):930–936.
4.
KohliHSBhaskaranMCMuthukumarT. Treatment-related acute renal failure in the elderly: a hospital-based prospective study. Nephrol Dial Transplant. 2000;15(2):212–217.
5.
DağMSAydınlıMOzturkZA. Drug- and herb-induced liver injury: a case series from a single center. Turk J Gastroenterol. 2014;25:41–45.
6.
SgroCClinardFOuazirK. Incidence of drug-induced hepatic injuries: a French population-based study. Hepatology. 2002;36(2):451–455.
7.
FriisHAndreasenPB. Drug-induced hepatic injury: an analysis of 1100 cases reported to the Danish committee on adverse drug reactions between 1978 and 1987. J Intern Med. 1992;232(2):133–138.
8.
PillansPI. Drug associated hepatic reactions in New Zealand: 21 years’ experience. N Z Med J. 1996;109(1028):315–319.
9.
DossingMAndreasenPB. Drug-induced liver disease in Denmark. An analysis of 572 cases of hepatotoxicity reported to the Danish board of adverse reactions to drugs. Scand J Gastroenterol. 1982;17(2):205–211.
10.
GalanMVPottsJASilvermanAL. The burden of acute nonfulminant drug-induced hepatitis in a United States tertiary referral center. J Clin Gastroenterol. 2005;39(1):64–67.
11.
OstapowiczGFontanaRJSchiodtFV. Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med. 2002;137(12):947–954.
12.
ChalasaniNFontanaRJBonkovskyHL. Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States. Gastroenterology. 2008;135(6):1924–1934.
13.
EstesJDStolpmanDOlyaeiA. High prevalence of potentially hepatotoxic herbal supplement use in patients with fulminant hepatic failure. Arch Surg. 2003;138(8):852–858.
14.
ScudderLMacyERimawiRHSolenskyR. Penicillin allergy: a mountain or a molehill?Medscape. Apr 30, 2014. Web site. http://www.medscape.com/viewarticle/824098. Accessed July 29, 2014.
